BioWorld Asia

Nov. 2, 2005

View Archived Issues

Map Of Changes Promises To Unmask Multitude Of Genes

NicOx Licenses Respiratory Drug To Topigen For 54.9M

CAT Paying $14M In Shares For Genencor Cancer Drugs

Ark's Gene Therapy Product Cerepro Under Review In EU

AM-Pharma Gets 9M In First Closing Of Series B Round

Other News To Note

CAT, Abbott Settle Humira Dispute: Abbott Pays $255M

Ending a 2-year-old dispute, Cambridge Antibody Technology plc and Abbott Laboratories reached an agreement concerning Humira royalties payable to CAT under a 1995 deal. (BioWorld International) Read More

2005's Second German IPO Prices At Low End Of Range

Today's news in brief

BioWorld

BioWorld briefs for Dec. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 24, 2024.

Illustration of neurons with Lewy bodies

Enhanced Cognition: Lewy body dementia phase II pumps stock

BioWorld

Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Lab glassware and antibodies art concept

Probing bidirectional cancer-autoimmune link can yield new targets

BioWorld Science

Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...